Advancements in cancer treatments and doctors’ understanding of acute myeloid leukemia (AML) mean that more and more people survive the condition each year. The 5-year overall survival rate for AML is ...
Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback